THERAPIX BIOSCI/S (NASDAQ:TRPX)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $0.53, but opened at $0.60. THERAPIX BIOSCI/S shares last traded at $0.62, with a volume of 390,900 shares.
Separately, ValuEngine raised THERAPIX BIOSCI/S from a “hold” rating to a “buy” rating in a research note on Thursday, April 2nd.
The company has a fifty day moving average price of $0.58 and a 200 day moving average price of $0.60. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 6.71.
THERAPIX BIOSCI/S Company Profile (NASDAQ:TRPX)
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Read More: What is the CAC 40 Index
Receive News & Ratings for THERAPIX BIOSCI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for THERAPIX BIOSCI/S and related companies with MarketBeat.com's FREE daily email newsletter.